135 related articles for article (PubMed ID: 7105045)
21. Positive interaction of bisbenzylisoquinoline alkaloid, cepharanthin, with vinca alkaloid agents against human tumors.
Ono M; Tanaka N
In Vivo; 1997; 11(3):233-41. PubMed ID: 9239517
[TBL] [Abstract][Full Text] [Related]
22. Effect of pentoxifylline on P-glycoprotein mediated vincristine resistance of L1210 mouse leukemic cell line.
Breier A; Barancík M; Stefanková Z; Uhrík B; Tribulová N
Neoplasma; 1994; 41(5):297-303. PubMed ID: 7854500
[TBL] [Abstract][Full Text] [Related]
23. Age-dependent cell inactivation by vincristine alone or in combination with 1-propargyl-5-chloropyrimidin-2-one.
Wibe E
Cancer Res; 1980 Jun; 40(6):2069-73. PubMed ID: 7371040
[TBL] [Abstract][Full Text] [Related]
24. NMR and mass spectrometric characterization of vinblastine, vincristine and some new related impurities--part II.
Háda V; Dubrovay Z; Lakó-Futó A; Galambos J; Gulyás Z; Aranyi A; Szántay C
J Pharm Biomed Anal; 2013 Oct; 84():309-22. PubMed ID: 23177164
[TBL] [Abstract][Full Text] [Related]
25. Overcoming of vincristine resistance in HL-60 human promyelocytic leukemia cell line by dipyridamole.
Hirose M; Takeda E; Kuroda Y
Tokushima J Exp Med; 1993 Jun; 40(1-2):27-33. PubMed ID: 8211977
[TBL] [Abstract][Full Text] [Related]
26. In situ selection of a human rhabdomyosarcoma resistant to vincristine with altered beta-tubulins.
Houghton JA; Houghton PJ; Hazelton BJ; Douglass EC
Cancer Res; 1985 Jun; 45(6):2706-12. PubMed ID: 3986804
[TBL] [Abstract][Full Text] [Related]
27. Interaction of vinca alkaloids with tubulin: a comparison of vinblastine, vincristine, and vinorelbine.
Lobert S; Vulevic B; Correia JJ
Biochemistry; 1996 May; 35(21):6806-14. PubMed ID: 8639632
[TBL] [Abstract][Full Text] [Related]
28. Relationship between the cellular accumulation and the cytotoxicity of S12363, a new Vinca alkaloid derivative.
Pierré A; Pérez V; Léonce S; Boutin JA; Saint-Dizier D; Hautefaye P; Lavielle G; Atassi G
Cancer Chemother Pharmacol; 1992; 29(5):367-74. PubMed ID: 1551175
[TBL] [Abstract][Full Text] [Related]
29. Studies with 4'-deoxyepivincristine (vinepidine), a semisynthetic vinca alkaloid.
Mullin K; Houghton PJ; Houghton JA; Horowitz ME
Biochem Pharmacol; 1985 Jun; 34(11):1975-9. PubMed ID: 4004913
[TBL] [Abstract][Full Text] [Related]
30. Uptake of Vinca alkaloids into mammalian nerve and its subcellular components.
Iqbal Z; Ochs S
J Neurochem; 1980 Jan; 34(1):59-68. PubMed ID: 6161213
[TBL] [Abstract][Full Text] [Related]
31. Correlation of cytotoxicity and mitotic spindle dissolution by vinblastine in mammalian cells.
Tucker RW; Owellen RJ; Harris SB
Cancer Res; 1977 Dec; 37(12):4346-51. PubMed ID: 922725
[TBL] [Abstract][Full Text] [Related]
32. Effect of phorbol myristate acetate (PMA) on P-glycoprotein mediated vincristine resistance of L1210 cells.
Barancík M; Stefanková Z; Breier A
Gen Physiol Biophys; 1995 Apr; 14(2):171-5. PubMed ID: 8846884
[TBL] [Abstract][Full Text] [Related]
33. Factors modifying the synergistic toxicity of deoxycytidine in combination with thymidine plus 5-fluorouracil in HeLa cells.
Fried J; Perez AG; Doblin JM; Clarkson BD
Cell Tissue Kinet; 1983 Nov; 16(6):539-48. PubMed ID: 6627345
[TBL] [Abstract][Full Text] [Related]
34. The effect of vincristine on mouse jejunal crypt cells of differing cell age: double labelling autoradiographic studies using 3H- and 14C-TdR.
Jellinghaus W; Schultze B; Maurer W
Cell Tissue Kinet; 1977 Mar; 10(2):147-56. PubMed ID: 856474
[TBL] [Abstract][Full Text] [Related]
35. Suppression of multidrug resistance by migrastatin.
Takemoto Y; Tashiro E; Imoto M
J Antibiot (Tokyo); 2006 Jul; 59(7):435-8. PubMed ID: 17025021
[TBL] [Abstract][Full Text] [Related]
36. Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR.
Tang XQ; Bi H; Feng JQ; Cao JG
Acta Pharmacol Sin; 2005 Aug; 26(8):1009-16. PubMed ID: 16038636
[TBL] [Abstract][Full Text] [Related]
37. Time dependence of [3H]-vincristine accumulation by L1210 mouse leukemic cells. Effect of P-glycoprotein overexpression.
Breier A; Stefanková Z; Barancík M; Tribulová N
Gen Physiol Biophys; 1994 Aug; 13(4):287-98. PubMed ID: 7890145
[TBL] [Abstract][Full Text] [Related]
38. Block of axoplasmic transport in vitro by vinca alkaloids.
Chan SY; Worth R; Ochs S
J Neurobiol; 1980 May; 11(3):251-64. PubMed ID: 6156229
[TBL] [Abstract][Full Text] [Related]
39. Energetics of vinca alkaloid interactions with tubulin isotypes: implications for drug efficacy and toxicity.
Lobert S; Frankfurter A; Correia JJ
Cell Motil Cytoskeleton; 1998; 39(2):107-21. PubMed ID: 9484953
[TBL] [Abstract][Full Text] [Related]
40. In vivo and in vitro pharmacokinetics and metabolism of vincaalkaloids in rat. II. Vinblastine and vincristine.
Zhou XJ; Martin M; Placidi M; Cano JP; Rahmani R
Eur J Drug Metab Pharmacokinet; 1990; 15(4):323-32. PubMed ID: 2088769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]